GlobalCare Expands into India and Russia
Drug Discovery & Development - June 23, 2011
Drug Discovery & Development - June 23, 2011
GlobalCare Clinical Trials, Ltd. announced an expansion into India and Russia to meet the demands of biopharmaceutical companies that want to increase clinical trials presence in the two countries, access large populations of treatment-naïve patients, and lower overall costs.
The company provides services to over 25 countries including the United States, Canada, Israel, Australia and countries in Latin America and throughout Europe.
“GlobalCare can deliver clinical trial services to these populations in settings like their home, office or alternate setting,” says Gail Adinamis, founder and chief executive officer of GlobalCare. “As the industry demand for optimized study logistics grows globally, we will continue to expand our network to keep pace with these needs.”
GlobalCare maintains a centrally managed network of GCP/ICH-trained and certified multilingual country coordinators with knowledge of local medical practices and country cultural attitudes. It has a network of more than 25,000 qualified local traveling physicians, nurses and phlebotomists.
source:GlobalCare Clinical Trials, Ltd.
The company provides services to over 25 countries including the United States, Canada, Israel, Australia and countries in Latin America and throughout Europe.
“GlobalCare can deliver clinical trial services to these populations in settings like their home, office or alternate setting,” says Gail Adinamis, founder and chief executive officer of GlobalCare. “As the industry demand for optimized study logistics grows globally, we will continue to expand our network to keep pace with these needs.”
GlobalCare maintains a centrally managed network of GCP/ICH-trained and certified multilingual country coordinators with knowledge of local medical practices and country cultural attitudes. It has a network of more than 25,000 qualified local traveling physicians, nurses and phlebotomists.
source:GlobalCare Clinical Trials, Ltd.
No comments:
Post a Comment